Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs — Six sites, 2005–2016

Kelly A. Jackson; Michele K. Bohm; John T. Brooks; Alice Asher; Joelle Nadle; Wendy M. Bamberg; Sue Petit; Susan M. Ray; Lee H. Harrison; Ruth Lynfield; Ghinwa Dumyati; William Schaffner; John M. Townes; Isaac See

doi:10.15585/mmwr.mm6722a2

Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs — Six sites, 2005–2016

Kelly A. Jackson, Michele K. Bohm, John T. Brooks, Alice Asher, Joelle Nadle, Wendy M. Bamberg, Sue Petit, Susan M. Ray, Lee H. Harrison, Ruth Lynfield, Ghinwa Dumyati, William Schaffner, John M. Townes, Isaac See

Infectious Diseases

Research output: Contribution to journal › Article › peer-review

99 Scopus citations

Abstract

What is already known about this topic? The ongoing opioid epidemic is associated with increases in human immunodeficiency virus and hepatitis C infections and infection syndromes such as endocarditis. What is added by this report? Persons who inject drugs were an estimated 16.3 times more likely to develop invasive methicillin-resistant Staphylococcus aureus (MRSA) infections than others. Invasive MRSA from injecting drugs increased from 4.1% of invasive MRSA cases to 9.2% (2011–2016). What are the implications for public health practice? Increases in nonsterile injection drug use can cause increases in MRSA infections, underscoring the importance of public health interventions, including prevention of opioid misuse, providing medication-assisted treatment, syringe services programs, and education on safer injection practices to prevent infections from skin flora.

Original language	English (US)
Pages (from-to)	625-628
Number of pages	4
Journal	Morbidity and Mortality Weekly Report
Volume	67
Issue number	22
DOIs	https://doi.org/10.15585/mmwr.mm6722a2
State	Published - Jun 8 2018

ASJC Scopus subject areas

Epidemiology
Health(social science)
Health, Toxicology and Mutagenesis
Health Information Management

Access to Document

10.15585/mmwr.mm6722a2

Cite this

Jackson, K. A., Bohm, M. K., Brooks, J. T., Asher, A., Nadle, J., Bamberg, W. M., Petit, S., Ray, S. M., Harrison, L. H., Lynfield, R., Dumyati, G., Schaffner, W., Townes, J. M., & See, I. (2018). Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs — Six sites, 2005–2016. Morbidity and Mortality Weekly Report, 67(22), 625-628. https://doi.org/10.15585/mmwr.mm6722a2

Jackson, KA, Bohm, MK, Brooks, JT, Asher, A, Nadle, J, Bamberg, WM, Petit, S, Ray, SM, Harrison, LH, Lynfield, R, Dumyati, G, Schaffner, W, Townes, JM & See, I 2018, 'Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs — Six sites, 2005–2016', Morbidity and Mortality Weekly Report, vol. 67, no. 22, pp. 625-628. https://doi.org/10.15585/mmwr.mm6722a2

@article{5a79ffef028a411aa4db1869cb812dad,

title = "Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs — Six sites, 2005–2016",

abstract = "What is already known about this topic? The ongoing opioid epidemic is associated with increases in human immunodeficiency virus and hepatitis C infections and infection syndromes such as endocarditis. What is added by this report? Persons who inject drugs were an estimated 16.3 times more likely to develop invasive methicillin-resistant Staphylococcus aureus (MRSA) infections than others. Invasive MRSA from injecting drugs increased from 4.1% of invasive MRSA cases to 9.2% (2011–2016). What are the implications for public health practice? Increases in nonsterile injection drug use can cause increases in MRSA infections, underscoring the importance of public health interventions, including prevention of opioid misuse, providing medication-assisted treatment, syringe services programs, and education on safer injection practices to prevent infections from skin flora.",

author = "Jackson, {Kelly A.} and Bohm, {Michele K.} and Brooks, {John T.} and Alice Asher and Joelle Nadle and Bamberg, {Wendy M.} and Sue Petit and Ray, {Susan M.} and Harrison, {Lee H.} and Ruth Lynfield and Ghinwa Dumyati and William Schaffner and Townes, {John M.} and Isaac See",

year = "2018",

month = jun,

day = "8",

doi = "10.15585/mmwr.mm6722a2",

language = "English (US)",

volume = "67",

pages = "625--628",

journal = "Morbidity and Mortality Weekly Report",

issn = "0149-2195",

publisher = "Department of Health and Human Services",

number = "22",

}

TY - JOUR

T1 - Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs — Six sites, 2005–2016

AU - Jackson, Kelly A.

AU - Bohm, Michele K.

AU - Brooks, John T.

AU - Asher, Alice

AU - Nadle, Joelle

AU - Bamberg, Wendy M.

AU - Petit, Sue

AU - Ray, Susan M.

AU - Harrison, Lee H.

AU - Lynfield, Ruth

AU - Dumyati, Ghinwa

AU - Schaffner, William

AU - Townes, John M.

AU - See, Isaac

PY - 2018/6/8

Y1 - 2018/6/8

N2 - What is already known about this topic? The ongoing opioid epidemic is associated with increases in human immunodeficiency virus and hepatitis C infections and infection syndromes such as endocarditis. What is added by this report? Persons who inject drugs were an estimated 16.3 times more likely to develop invasive methicillin-resistant Staphylococcus aureus (MRSA) infections than others. Invasive MRSA from injecting drugs increased from 4.1% of invasive MRSA cases to 9.2% (2011–2016). What are the implications for public health practice? Increases in nonsterile injection drug use can cause increases in MRSA infections, underscoring the importance of public health interventions, including prevention of opioid misuse, providing medication-assisted treatment, syringe services programs, and education on safer injection practices to prevent infections from skin flora.

AB - What is already known about this topic? The ongoing opioid epidemic is associated with increases in human immunodeficiency virus and hepatitis C infections and infection syndromes such as endocarditis. What is added by this report? Persons who inject drugs were an estimated 16.3 times more likely to develop invasive methicillin-resistant Staphylococcus aureus (MRSA) infections than others. Invasive MRSA from injecting drugs increased from 4.1% of invasive MRSA cases to 9.2% (2011–2016). What are the implications for public health practice? Increases in nonsterile injection drug use can cause increases in MRSA infections, underscoring the importance of public health interventions, including prevention of opioid misuse, providing medication-assisted treatment, syringe services programs, and education on safer injection practices to prevent infections from skin flora.

UR - http://www.scopus.com/inward/record.url?scp=85048114379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048114379&partnerID=8YFLogxK

U2 - 10.15585/mmwr.mm6722a2

DO - 10.15585/mmwr.mm6722a2

M3 - Article

C2 - 29879096

AN - SCOPUS:85048114379

SN - 0149-2195

VL - 67

SP - 625

EP - 628

JO - Morbidity and Mortality Weekly Report

JF - Morbidity and Mortality Weekly Report

IS - 22

ER -

Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs — Six sites, 2005–2016

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this